Concepedia

Sujatha Menon

SM

Statistics

Publications

31

Citations

5.5K

H-Index

22

Active since

2003

Affiliations

Pfizer (United States)(Current)

University of Toronto

University of Washington

Altoona Center for Clinical Research

Toronto Western Hospital

Sujatha Menon is an author at Pfizer (United States) specializing in pharmacology, rheumatology, and medicine.

Publications per year

2003–2024

31

Publications

31

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg, Deepak L. Bhatt, Ted R. Mikuls et al. · New England Journal of Medicine · 2022 · 1.7K citations · Full text

, , +15

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

Philip J. Mease, Stephen Hall, Oliver FitzGerald et al. · New England Journal of Medicine · 2017 · 560 citations

, , +14

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Dafna D. Gladman, William F. C. Rigby, Valderílio Feijó Azevedo et al. · New England Journal of Medicine · 2017 · 508 citations · Full text

, , +14

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

, , +12

The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

Jennifer Hodge, Thomas T. Kawabata, Sriram Krishnaswami et al. · PubMed · 2016 · 372 citations

, , +17

1–5 of 31